Clinical Trial

Evaluation of the PROSTia Test in Patients Undergoing Prostate Biopsy

Study acronym: PROSTIA- BP
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators are interested here in the contribution of a new prostate cancer screening method and, more specifically, in the new and somewhat futuristic approach of artificial intelligence in the development of new, more accurate algorithms that make it possible to rethink the benefits of mass generalisation of prostate biopsies. Main objective The main objective of this research is to use artificial intelligence and an associated algorithm to identify new indicators that would make it possible to avoid a prostate biopsy in patients with an initial suspicion of prostate cancer.
Trial Details
NCT Number NCT06931496
Lead Sponsor Central Hospital, Nancy, France
Conditions Prostate Cancer (Adenocarcinoma)
Enrollment 150 participants
Start Date 2025-04-15
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-17